期刊文献+

围生期下肢深静脉血栓形成12例临床分析 被引量:7

Clinical analysis of 12 cases with deep venous thrombosis of lower extremity at perinatal
下载PDF
导出
摘要 目的通过分析围生期下肢静脉血栓患者的病例特点,总结围生期下肢深静脉血栓形成的预防与治疗经验。方法整理分析佛山市禅城区中心医院2000年1月~2013年1月12例围生期血栓性疾病的临床资料,系统分析其临床特点。结果围生期下肢静脉血栓发生于产褥期10例(83.3%),其中发生在剖宫产术后7例(70.0%);左下肢深静脉血栓(DVT)6例(50.0%),单纯发生于肢体近端DVT 9例(75.0%);股静脉血栓形成10例(83.3%);孕期规律检查9例(75.0%);卧床时间>3 d出现DVT 8例(66.7%);12例DVT患者均行彩色多普勒超声检查确诊。结论围生期血栓疾病预防在于孕期产检中注意评估选高危人群,早期进行干预,以减少围生期血栓性疾病的发生。治疗方案以低分子肝素为主,联合中成药及物理治疗为主,必要时可溶栓治疗。 Objective To make clinical analysis and summary of the experience of prevention and treatment of lower limb vein thrombus at perinatal. Methods 12 cases of deep venous thrombosis of lower extremity at perinatal between January 2000 to January 2013 were collected, the clinical data was analyzed and the clinical characteristics were sum- marized. Results 10 cases (83.3%) of perinatal period of lower extremity venous thrombosis occurred in the puerperium, 7 cases (70.0%) occurred after cesarean section; 6 cases (50.0%) occurred in the left lower extremity, 9 cases (75.0%) occurred in the proximal limb; 10 cases (83.3%) were femoral vein thrombosis; 9 cases (75.0%) were pregnancy law, 8 cases (66.7%) occurred at the bedridden time 〉 3 days. All patients were underwented with the color doppler ultra- sound diagnosis. Conclusion The perinatal thrombus disease prevention key is the assessing the high-risk population and the pregnancy inspection, the early intervention can reduce the incidence of perinatal thrombotic diseasesand. The treatment is using low molecular weight heparin, or combining with traditional Chinese medicine, physical therapy, and thrombolytic therapy when necessary.
出处 《中国医药导报》 CAS 2014年第11期31-33,37,共4页 China Medical Herald
基金 广东省佛山市医学类科技攻关项目(编号2012 08111)
关键词 围生期 下肢深静脉血栓 低分子肝素 Perinatal period Deep venous thrombosis of lower extremity Ix^w molecular weight heparin
  • 相关文献

参考文献15

  • 1Thomas TA, Cooper GM. Maternal deaths from anaesthesia. An extract from why mothers die 1997-1999,the confi- dential enquiries into maternal deaths in the United King- dom [J]. Br J Anaesth, 2002,89 (3) :499-508.
  • 2Cosmi B, Legnani C, Bernardi F, et al. Value of family his- tory in identifying women at risk of venous thromboem- bolism during oral contraception: observational study [J]. BMJ,2001,322(7293) : 1024-1025.
  • 3Cumming AM,Shiach CR. The investigation and manage- ment of inherited thrombophilia [J]. Clin Lab Haematol, 1999,21 (2) :77-92.
  • 4Wells PS,Anderson DR, Ginsberg J. Assesssment of deep veinthrombosis or pulmonary embolism by the combined use of clinical model and noninvasive diagnostic tests [J]. Semin Thromb Hemost, 2000, (26) : 643-656.
  • 5Ahearn GS, I-Iadjiliadis D, Govert JA,et al. Massive pul- monary embolism during pregnancy successfully treated with recombinant tissue plasminogen activator: a case re- port and review of treatment options [J]. Arch Intern Med, 2002,162(11 ) : 1221-1227.
  • 6James AH. Pregnancy-associated thrombosis [J]. Hematol- ogy Am Soc Hematol Educ Program,2009,194(5) :277-285.
  • 7Chan WS,Spencer FA, Ginsberg JS. Anatomic distribution of deep vein thrombosis in pregnancy [J]. CMAJ, 2010,182 (7) : 657-660.
  • 8Deneux TC, Carmona E, Bouvier CM, et al. Postpartum ma- ternal mortality and cesarean delivery [J]. Obstet Gynecol, 2006,108 (3) : 541-548.
  • 9Sephton V, Farquharson RG,Topping J, et al. A longitudinal study of maternal dose response to low molecular weight heparin in pregnancy [J]. Obstet Gyneeol,2003,101 (6) : 1307-1311.
  • 10Greaves M. Limitations of the laboratory monitoring of hep- arin therapy Scientific and Standardization Committee Corn mumunications [J]. Thromb Haemost,2002,87 (1):163- 164.

二级参考文献33

  • 1FRANCO R F,REITSMA P H.Genetic risk factors ofvenous thrombosis[J].Hum Genet,2001,109(4):369-384.
  • 2BARCZYK A,PIERZCHALA W.Risk factors of venous thromboembolism[J].Wiad Lek,2001,54(5-6):311-324.
  • 3LEVINE A B,TEPPA J,McGOUGH B,et al.Evaluation of the prethrombotic stae in pregnancy and in women using oral contraceptives[J].Contraception,1997,55(1):53.
  • 4GRUBER U F,DUCKERT F,FRIDRICH R,et al.Prevention of postoperative thromboembolism by dextran 40,low doses of heparin,orxantinolnicotinate[J].Lancet,1997,1:210.
  • 5HEIT J A,KOBBERVIG C E,JAMES A H. Trends in the incidence of venous thromboembolism during pregnancy or postpartum:a 30-year population-based study[J].Annals of Internal Medicine,2005,(10):697-706.
  • 6POMP E R,LENSELINK A M,ROSENDAAL F R. Pregnancy,the postpartum period and prothrombotic defects:risk of venous thrombosis in the MEGA study[J].Journal of Thrombosis and Haemostasis,2008,(04):632-637.doi:10.1111/j.1538-7836.2008.02921.x.
  • 7JAMES A H,JAMISON M G,BRANCAZIO L R. Venous thromboembolism during pregnancy and the postpartum period:incidence,risk factors,and mortality[J].American Journal of Obstetrics and Gynecology,2006,(05):1311-1315.doi:10.1016/j.ajog.2005.11.008.
  • 8SIMPSON E L,LAWRENSON R A,NIGHTINGALE A L. Venous thromboembolism in pregnancy and the puerperium:incidence and additional risk factors from a London perinatal database[J].British Journal of Obstetrics and Gynaecology,2001,(01):56-60.
  • 9BERG C J,CALLAGHAN W M,SYVERSON C. Pregnancy-related mortality in the United States,1998 to 2005[J].Obstetrics and Gynecology,2010,(06):1302-1309.
  • 10JAMES A H. Pregnancy-associated thrombosis[J].Hematology(American Society Hematology Education Program),2009,(05):277-285.

共引文献74

同被引文献52

引证文献7

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部